Decode With Confidence

AI-powered clarity for every variant. Smarter analysis. Better patient outcomes.

AI Agent

Vicuña

Your genomics copilot

A conversational AI agent purpose-built for variant analysis. Vicuña guides clinicians through complex genomic data with natural language, integrating clinical evidence and the latest literature.

  • Evidence-driven, guideline-compliant classification
    Aggregates clinical evidence from ClinVar, gnomAD, literature, and functional data — aligned with ACMG/AMP guidelines.
  • Integrated tool & database access
    Query annotation sources, external databases, and specialized analysis tools directly within the conversation.
  • Human-in-the-loop case summarization
    Distill complex multi-variant cases into structured clinical summaries ready for review — with clinician oversight at every step.

Vicuña Assistant

What is the clinical significance of BRCA2 c.5946delT?

BRCA2 c.5946delT (p.Ser1982ArgfsTer22) is classified as **Pathogenic** by ClinVar. This frameshift variant in exon 11 disrupts the DNA repair domain. Associated with hereditary breast-ovarian cancer syndrome. 47 submitters support this classification.

Show me the ACMG criteria breakdown.

From dialogue to diagnosis.

Built AI-native from the ground up.

Platform

Noxia

VCF to signed-out report.

Noxia is a clinical-grade variant analysis platform that transforms raw VCF files into regulatory-ready clinical reports.

1.

Upload

Import VCF files directly or via LIMS integration

2.

Annotate & Classify

AI-powered ACMG/AMP classification with evidence aggregation

3.

Review & Collaborate

Team-based review with comments, assignments, and role-based access

4.

Sign-Out & Report

PDF generation with full audit trail

NOXIA
CasesVariantsReportsSettings

Case WES-2024-0847

18 variants · 3 in Review

Variant Gene Classification Status
chr17:7674220 C>T TP53 Pathogenic Reviewed
chr2:47702181 G>A MSH2 Likely Pathogenic Pending
chr7:55249071 T>G EGFR VUS Pending
chr13:32929387 A>C BRCA2 Benign Reviewed

Agentic AI, harnessed by clinicians.

noxia.viknox.com

Dashboard

WES-2024-0847 Priority
WES-2024-0851 Pending
WES-2024-0853 Pending

Case WES-2024-0847

18 variants · 3 in Review

Gene Classification
TP53 Pathogenic
MSH2 Unclassified
BRCA2 Benign

MSH2 c.942+3A>T

Classifying...
ClinGen specification queried
PubMed search...

MSH2 c.942+3A>T

Likely Pathogenic Pending Approval
ACMG: PVS1 PM2 PP3
ClinVar: 3 submissions (LP)
gnomAD: absent

Report — WES-2024-0847

TP53 Reviewed
MSH2 Approved
AI Coding Agent

>

>

>

>

>

Get Started

Decode with confidence.

Request a demo to see how Viknox transforms your variant analysis workflow — from VCF to signed-out report.